Literature DB >> 16909907

Epigenotypes of latent herpesvirus genomes.

J Minarovits1.   

Abstract

Epigenotypes are modified cellular or viral genotypes which differ in transcriptional activity in spite of having an identical (or nearly identical) DNA sequence. Restricted expression of latent, episomal herpesvirus genomes is also due to epigenetic modifications. There is no virus production (lytic viral replication, associated with the expression of all viral genes) in tight latency. In vitro experiments demonstrated that DNA methylation could influence the activity of latent (and/or crucial lytic) promoters of prototype strains belonging to the three herpesvirus subfamilies (alpha-, beta-, and gamma-herpesviruses). In vivo, however, DNA methylation is not a major regulator of herpes simplex virus type 1 (HSV-1, a human alpha-herpesvirus) latent gene expression in neurons of infected mice. In these cells, the promoter/enhancer region of latency-associated transcripts (LATs) is enriched with acetyl histone H3, suggesting that histone modifications may control HSV-1 latency in terminally differentiated, quiescent neurons. Epstein-Barr virus (EBV, a human gamma-herpesvirus) is associated with a series of neoplasms. Latent, episomal EBV genomes are subject to host cell-dependent epigenetic modifications (DNA methylation, binding of proteins and protein complexes, histone modifications). The distinct viral epigenotypes are associated with distinct EBV latency types, i.e., cell type-specific usage of latent EBV promoters controlling the expression of latent, growth transformation-associated EBV genes. The contribution of major epigenetic mechanisms to the regulation of latent EBV promoters is variable. DNA methylation contributes to silencing of Wp and Cp (alternative promoters for transcripts coding for the nuclear antigens EBNA 1-6) and LMP1p, LMP2Ap, and LMP2Bp (promoters for transcripts encoding transmembrane proteins). DNA methylation does not control, however, Qp (a promoter for EBNA1 transcripts only) in lymphoblastoid cell lines (LCLs), although in vitro methylated Qp-reporter gene constructs are silenced. The invariably unmethylated Qp is probably switched off by binding of a repressor protein in LCLs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16909907     DOI: 10.1007/3-540-31181-5_5

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  36 in total

1.  The lytic phase of epstein-barr virus requires a viral genome with 5-methylcytosine residues in CpG sites.

Authors:  Markus Kalla; Christine Göbel; Wolfgang Hammerschmidt
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

2.  Chromatin profiling of Epstein-Barr virus latency control region.

Authors:  Latasha Day; Charles M Chau; Michael Nebozhyn; Andrew J Rennekamp; Michael Showe; Paul M Lieberman
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

3.  High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1.

Authors:  Agnes Bakos; Ferenc Banati; Anita Koroknai; Maria Takacs; Daniel Salamon; Susanna Minarovits-Kormuta; Fritz Schwarzmann; Hans Wolf; Hans Helmut Niller; Janos Minarovits
Journal:  Virus Genes       Date:  2007-05-18       Impact factor: 2.332

4.  AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome.

Authors:  Markus Kalla; Anne Schmeinck; Martin Bergbauer; Dagmar Pich; Wolfgang Hammerschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

5.  Restricted TET2 Expression in Germinal Center Type B Cells Promotes Stringent Epstein-Barr Virus Latency.

Authors:  Coral K Wille; Yangguang Li; Lixin Rui; Eric C Johannsen; Shannon C Kenney
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

6.  The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes.

Authors:  Thomas Günther; Adam Grundhoff
Journal:  PLoS Pathog       Date:  2010-06-03       Impact factor: 6.823

7.  An in vitro system for studying murid herpesvirus-4 latency and reactivation.

Authors:  Janet S May; Neil J Bennett; Philip G Stevenson
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

8.  Evaluation of a prediction protocol to identify potential targets of epigenetic reprogramming by the cancer associated Epstein Barr virus.

Authors:  Kirsty Flower; Elizabeth Hellen; Melanie J Newport; Susan Jones; Alison J Sinclair
Journal:  PLoS One       Date:  2010-02-26       Impact factor: 3.240

9.  CTCF prevents the epigenetic drift of EBV latency promoter Qp.

Authors:  Italo Tempera; Andreas Wiedmer; Jayaraju Dheekollu; Paul M Lieberman
Journal:  PLoS Pathog       Date:  2010-08-12       Impact factor: 6.823

Review 10.  Keeping it quiet: chromatin control of gammaherpesvirus latency.

Authors:  Paul M Lieberman
Journal:  Nat Rev Microbiol       Date:  2013-11-06       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.